Selected research
Market Structure
Global Skin Microbiome Modulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Skin Microbiome Modulator market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Skin Microbiome Modulator include L’Oréal S.A., Unilever, The Estée Lauder Companies, Johnson & Johnson, Revlon, Evelo Biosciences, AOBiome, Azitra and GALLINÉE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Skin Microbiome Modulator market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Skin Microbiome Modulator and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Skin Microbiome Modulator revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Skin Microbiome Modulator market size, projected growth trends, production technologies, key applications, and end-use industries.
Skin Microbiome Modulator Segment by Company
L’Oréal S.A.
Unilever
The Estée Lauder Companies
Johnson & Johnson
Revlon
Evelo Biosciences
AOBiome
Azitra
GALLINÉE
Glowbiotics
Skin Microbiome Modulator Segment by Type
Probiotics
Prebiotics
Drugs
Skin Microbiome Modulator Segment by Application
Skin Care
Hair Care
Others
Skin Microbiome Modulator Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Microbiome Modulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Microbiome Modulator and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Microbiome Modulator.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Skin Microbiome Modulator in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Microbiome Modulator industry.
Chapter 3: Detailed analysis of Skin Microbiome Modulator companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Microbiome Modulatorrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Probiotics
- Prebiotics
- Drugs
Applications
- Skin Care
- Hair Care
- Others
Companies covered
- L’Oréal S.A.
- Unilever
- The Estée Lauder Companies
- Johnson & Johnson
- Revlon
- Evelo Biosciences
- AOBiome
- Azitra
- GALLINÉE
- Glowbiotics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Skin Microbiome Modulator Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Probiotics
- 1.2.3 Prebiotics
- 1.2.4 Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Skin Microbiome Modulator Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Skin Care
- 1.3.3 Hair Care
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Skin Microbiome Modulator Growth Trends by Region
- 1.5.1 Global Skin Microbiome Modulator Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Skin Microbiome Modulator Market Size by Region (2021-2026)
- 1.5.3 Skin Microbiome Modulator Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Skin Microbiome Modulator Market Dynamics
- 2.1 Skin Microbiome Modulator Industry Trends
- 2.2 Skin Microbiome Modulator Industry Drivers
- 2.3 Skin Microbiome Modulator Industry Opportunities and Challenges
- 2.4 Skin Microbiome Modulator Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Skin Microbiome Modulator Revenue by Company (2021-2026)
- 3.2 Global Skin Microbiome Modulator Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Skin Microbiome Modulator Key Company Head office and Area Served
- 3.4 Global Skin Microbiome Modulator Company, Product Type & Application
- 3.5 Global Skin Microbiome Modulator Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Skin Microbiome Modulator Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Skin Microbiome Modulator Players Market Share by Revenue in 2025
- 3.6.3 2025 Skin Microbiome Modulator Tier 1, Tier 2, and Tier 3
4 Skin Microbiome Modulator Market by Type
- 4.1 Global Skin Microbiome Modulator Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Skin Microbiome Modulator Market Size by Type (2021-2032)
- 4.3 Global Skin Microbiome Modulator Market Size Share by Type (2021-2032)
5 Skin Microbiome Modulator Market by Application
- 5.1 Global Skin Microbiome Modulator Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Skin Microbiome Modulator Market Size by Application (2021-2032)
- 5.3 Global Skin Microbiome Modulator Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 L’Oréal S.A.
- 6.1.1 L’Oréal S.A. Company Information
- 6.1.2 L’Oréal S.A. Business Overview
- 6.1.3 L’Oréal S.A. Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 L’Oréal S.A. Skin Microbiome Modulator Product Portfolio
- 6.1.5 L’Oréal S.A. Recent Developments
- 6.2 Unilever
- 6.2.1 Unilever Company Information
- 6.2.2 Unilever Business Overview
- 6.2.3 Unilever Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Unilever Skin Microbiome Modulator Product Portfolio
- 6.2.5 Unilever Recent Developments
- 6.3 The Estée Lauder Companies
- 6.3.1 The Estée Lauder Companies Company Information
- 6.3.2 The Estée Lauder Companies Business Overview
- 6.3.3 The Estée Lauder Companies Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 The Estée Lauder Companies Skin Microbiome Modulator Product Portfolio
- 6.3.5 The Estée Lauder Companies Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Company Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Johnson & Johnson Skin Microbiome Modulator Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 Revlon
- 6.5.1 Revlon Company Information
- 6.5.2 Revlon Business Overview
- 6.5.3 Revlon Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Revlon Skin Microbiome Modulator Product Portfolio
- 6.5.5 Revlon Recent Developments
- 6.6 Evelo Biosciences
- 6.6.1 Evelo Biosciences Company Information
- 6.6.2 Evelo Biosciences Business Overview
- 6.6.3 Evelo Biosciences Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Evelo Biosciences Skin Microbiome Modulator Product Portfolio
- 6.6.5 Evelo Biosciences Recent Developments
- 6.7 AOBiome
- 6.7.1 AOBiome Company Information
- 6.7.2 AOBiome Business Overview
- 6.7.3 AOBiome Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AOBiome Skin Microbiome Modulator Product Portfolio
- 6.7.5 AOBiome Recent Developments
- 6.8 Azitra
- 6.8.1 Azitra Company Information
- 6.8.2 Azitra Business Overview
- 6.8.3 Azitra Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Azitra Skin Microbiome Modulator Product Portfolio
- 6.8.5 Azitra Recent Developments
- 6.9 GALLINÉE
- 6.9.1 GALLINÉE Company Information
- 6.9.2 GALLINÉE Business Overview
- 6.9.3 GALLINÉE Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 GALLINÉE Skin Microbiome Modulator Product Portfolio
- 6.9.5 GALLINÉE Recent Developments
- 6.10 Glowbiotics
- 6.10.1 Glowbiotics Company Information
- 6.10.2 Glowbiotics Business Overview
- 6.10.3 Glowbiotics Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Glowbiotics Skin Microbiome Modulator Product Portfolio
- 6.10.5 Glowbiotics Recent Developments
7 North America
- 7.1 North America Skin Microbiome Modulator Market Size (2021-2032)
- 7.2 North America Skin Microbiome Modulator Market Size by Type
- 7.2.1 North America Skin Microbiome Modulator Market Size by Type (2021-2026)
- 7.2.2 North America Skin Microbiome Modulator Market Size by Type (2027-2032)
- 7.2.3 North America Skin Microbiome Modulator Market Share by Type (2021-2032)
- 7.3 North America Skin Microbiome Modulator Market Size by Application
- 7.3.1 North America Skin Microbiome Modulator Market Size by Application (2021-2026)
- 7.3.2 North America Skin Microbiome Modulator Market Size by Application (2027-2032)
- 7.3.3 North America Skin Microbiome Modulator Market Share by Application (2021-2032)
- 7.4 North America Skin Microbiome Modulator Market Size by Country
- 7.4.1 North America Skin Microbiome Modulator Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Skin Microbiome Modulator Market Size by Country (2021-2026)
- 7.4.3 North America Skin Microbiome Modulator Market Size by Country (2027-2032)
- 7.4.4 North America Skin Microbiome Modulator Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Skin Microbiome Modulator Market Size (2021-2032)
- 8.2 Europe Skin Microbiome Modulator Market Size by Type
- 8.2.1 Europe Skin Microbiome Modulator Market Size by Type (2021-2026)
- 8.2.2 Europe Skin Microbiome Modulator Market Size by Type (2027-2032)
- 8.2.3 Europe Skin Microbiome Modulator Market Share by Type (2021-2032)
- 8.3 Europe Skin Microbiome Modulator Market Size by Application
- 8.3.1 Europe Skin Microbiome Modulator Market Size by Application (2021-2026)
- 8.3.2 Europe Skin Microbiome Modulator Market Size by Application (2027-2032)
- 8.3.3 Europe Skin Microbiome Modulator Market Share by Application (2021-2032)
- 8.4 Europe Skin Microbiome Modulator Market Size by Country
- 8.4.1 Europe Skin Microbiome Modulator Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Skin Microbiome Modulator Market Size by Country (2021-2026)
- 8.4.3 Europe Skin Microbiome Modulator Market Size by Country (2027-2032)
- 8.4.4 Europe Skin Microbiome Modulator Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Skin Microbiome Modulator Market Size (2021-2032)
- 9.2 China Skin Microbiome Modulator Market Size by Type
- 9.2.1 China Skin Microbiome Modulator Market Size by Type (2021-2026)
- 9.2.2 China Skin Microbiome Modulator Market Size by Type (2027-2032)
- 9.2.3 China Skin Microbiome Modulator Market Share by Type (2021-2032)
- 9.3 China Skin Microbiome Modulator Market Size by Application
- 9.3.1 China Skin Microbiome Modulator Market Size by Application (2021-2026)
- 9.3.2 China Skin Microbiome Modulator Market Size by Application (2027-2032)
- 9.3.3 China Skin Microbiome Modulator Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Skin Microbiome Modulator Market Size (2021-2032)
- 10.2 Asia Skin Microbiome Modulator Market Size by Type
- 10.2.1 Asia Skin Microbiome Modulator Market Size by Type (2021-2026)
- 10.2.2 Asia Skin Microbiome Modulator Market Size by Type (2027-2032)
- 10.2.3 Asia Skin Microbiome Modulator Market Share by Type (2021-2032)
- 10.3 Asia Skin Microbiome Modulator Market Size by Application
- 10.3.1 Asia Skin Microbiome Modulator Market Size by Application (2021-2026)
- 10.3.2 Asia Skin Microbiome Modulator Market Size by Application (2027-2032)
- 10.3.3 Asia Skin Microbiome Modulator Market Share by Application (2021-2032)
- 10.4 Asia Skin Microbiome Modulator Market Size by Country
- 10.4.1 Asia Skin Microbiome Modulator Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Skin Microbiome Modulator Market Size by Country (2021-2026)
- 10.4.3 Asia Skin Microbiome Modulator Market Size by Country (2027-2032)
- 10.4.4 Asia Skin Microbiome Modulator Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Skin Microbiome Modulator Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Type
- 11.2.1 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Skin Microbiome Modulator Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Application
- 11.3.1 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Skin Microbiome Modulator Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Country
- 11.4.1 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Skin Microbiome Modulator Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Skin Microbiome Modulator Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst